论文部分内容阅读
目的探讨甲氨蝶呤(Methotrexate,MTX)联合宫腹腔镜监测行刮宫术治疗早期剖宫产瘢痕妊娠(cesarean scar pregnancy,CSP)的可行性。方法回顾性分析2010年3月至2012年7月符合条件的剖宫产术后子宫瘢痕部位妊娠21例患者的临床资料。结果 21例患者中17例完全成功,3例未一次性刮净,术后药物治疗成功;1例穿孔,腹腔镜下缝合。所有病例无大出血等并发症。结论 MTX联合宫腹腔镜监测行刮宫术治疗早期CSP,成功率高,安全有效。
Objective To investigate the feasibility of methotrexate (MTX) combined with hysteroscopy in the treatment of early cesarean scar pregnancy (CSP) undergoing curettage. Methods The clinical data of 21 cases of uterine scar pregnancy after cesarean section between March 2010 and July 2012 were retrospectively analyzed. Results Of the 21 cases, 17 cases were completely successful, 3 cases were not scraped once and the drug was successfully treated. One case was perforation and laparoscopic suture. No bleeding and other complications in all cases. Conclusion MTX combined with hysteroscopy in the treatment of early CSP curettage, high success rate, safe and effective.